Search for: "LILLI JOHNSON" Results 201 - 220 of 242
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Sep 2008, 3:26 pm
Et tu Johnson & Johnson, Pfizer, Merck, GlaxoSmithKline, or AstraZeneca?? [read post]
11 Sep 2008, 8:05 am by jdc
Click on the link http://www.covits.org/governor’s_technology_awards/index.cfm and scroll down to see a picture of ACR members Lilli Hausenfluck and Joe Johnson with Virginia Governor Tim Kaine after receiving the 2008 Governor’s Technology Award in the category of “Cross-boundary Collaboration. [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
8 Aug 2008, 5:00 pm
We haven't yet said a peep about the FAS 5 brouhaha.And, Lord knows, we haven't had to.In a nutshell, the Financial Accounting Standards Board has proposed to amend FASB Statement No. 5 to require companies to make additional disclosures about pending "loss contingencies," which means making more public statements about pending litigation.For some of the massive reaction to FASB's proposal, see The Wall Street Journal's editorial on August 7 or the D and O Diary or… [read post]
4 Aug 2008, 7:06 pm
Lilly, No. 06-2613 Denial of an inmate's habeas petition based upon ineffective assistance of counsel is affirmed where there was sufficient evidence for a jury to have convicted defendant, and therefore no prejudice to defendant resulted from heeding his attorney's advice to waive a jury trial. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
21 Jul 2008, 2:41 pm
Pugh stepped down after receiving 49.9 percent opposition, while Stever and director Charles Lillis received more than 40 percent negative votes. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over Special 301… [read post]
30 Jun 2008, 1:43 pm
Drug companies such as Eli Lilly & Co, Japan's Daiichi Sankyo Co. and... [read post]
30 May 2008, 9:09 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
23 Apr 2008, 1:52 am
Chris Dodd on April 21, 200804/22/2008 Letter and Corresponding Documents to EPA Administrator Stephen Johnson From House Oversight and Government Reform Chairman Henry Waxman (PDF 2.25 MB) Correspondence Regarding BHP Billiton Liquefied Natural Gas Project Off the Coast of Ventura County, California Dated March 5, 200704/22/2008 Letter Between Sen. [read post]
8 Apr 2008, 12:25 am
The NYT has posted an insightful article about the realities of preemption, and specifically Johnson & Johnson and its Ortho Evra Patch. [read post]
28 Mar 2008, 7:25 am
Proponents have withdrawn resolutions at Abbott Laboratories, Aetna, Bristol-Myers Squibb, Eli Lilly, General Electric, IBM, Johnson & Johnson, McDonald's, Medco, WellPoint, ExxonMobil, Merck, Target, and Waste Management after many of the companies agreed to post statements on health care reform on their Web sites. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
15 Jan 2008, 3:06 am
Johnson Outdoors, Inc, filed 03/14/07   closed 07/25/07 1:07-cv-01490 Electronic Imaging Systems of America, Inc. v. [read post]